FDA Approves Drug That Targets Brain Cancer Gene Mutation That Could Delay Need for Radiation and Chemotherapy
www.goodnewsnetwork.org
A new targeted drug for low-grade glioma brain cancer was approved the FDA—treating the IDH-mutant gene discovered 16 years ago.